Childhood asthma may increase risk of type 1 diabetes and IBD

Published Date: 17 Mar 2023

Denmark: COPSAC, Copenhagen Prospective Study of Childhood Asthma, researchers in Copenhagen, Denmark, noted that a higher risk...

Read Full News

Latest News

No Racial Differences Appear in Common COPD Scores

Results support the need for attention to social determinants of health and health system disparities.

COPD and Heart Disease Demand Integrated Clinical Care

Failing to look beyond spirometry in COPD costs lives. Experts at ERS 2026 present new clinical guidance to unify cardiovascular and respiratory management.

Roivant's Experimental Lung Disease Drug Meets Goals in Mid-stage Study

Roivant said on Tuesday its experimental drug met the main goals of a mid-stage study in patients ⁠with high blood pressure associated with a type of lung disease, sending...

Shared Decision-Making in Pediatric Lung Care

Effective communication, empathy amid medical uncertainty, and structured transition plans improve pediatric pulmonary care and the transition to adult care.

Advances in Care for Rare Pediatric Lung Diseases

Living with a rare lung condition can be especially challenging, but research into interogran cross talk and organoid models, and cross-border registry are improving outcomes.

US CDC Records More Than 3,100 Measles Cases So Far in 2026

The U.S. Centers for Disease Control and Prevention said on Friday there were 3,134 confirmed measles ⁠cases in the country so far this year, marking the highest annual...

Todays Updates

First-Line T-DXd Boosts PFS in HER2-Mutant NSCLC

DESTINY-Lung04 supports trastuzumab deruxtecan as a new frontline option for patients with advanced HER2-mutant disease, though it failed to improve overall survival.

Could Burnout Become the Employer’s Responsibility?

A European Parliament committee is backing employer risk assessments to tackle burnout. But should that mean new binding EU rules?

High CLL Remission Seen With First-Line Triplet Regimen

High 2-year survival rates are seen in treatment-naive patients with CLL receiving a noncovalent BTK inhibitor combined with venetoclax and obinutuzumab.

FET-PET Agent Approved for Glioma Imaging

Floretyrosine F18 is the first amino acid PET imaging agent approved for glioma in the United States.

Todays Updates

First-Line T-DXd Boosts PFS in HER2-Mutant NSCLC

DESTINY-Lung04 supports trastuzumab deruxtecan as a new frontline option for patients with advanced HER2-mutant disease, though it failed to improve overall survival.

Could Burnout Become the Employer’s Responsibility?

A European Parliament committee is backing employer risk assessments to tackle burnout. But should that mean new binding EU rules?

High CLL Remission Seen With First-Line Triplet Regimen

High 2-year survival rates are seen in treatment-naive patients with CLL receiving a noncovalent BTK inhibitor combined with venetoclax and obinutuzumab.

FET-PET Agent Approved for Glioma Imaging

Floretyrosine F18 is the first amino acid PET imaging agent approved for glioma in the United States.

Latest News

Results support the need for attention to social determinants of health and health system disparities.

Failing to look beyond spirometry in COPD costs lives. Experts at ERS 2026 present new clinical guidance to unify cardiovascular and respiratory management.

Roivant said on Tuesday its experimental drug met the main goals of a mid-stage study in patients ⁠with high blood pressure associated with a type of lung disease, sending...

Effective communication, empathy amid medical uncertainty, and structured transition plans improve pediatric pulmonary care and the transition to adult care.

Living with a rare lung condition can be especially challenging, but research into interogran cross talk and organoid models, and cross-border registry are improving outcomes.

The U.S. Centers for Disease Control and Prevention said on Friday there were 3,134 confirmed measles ⁠cases in the country so far this year, marking the highest annual...

News All Time

Wildfire Smoke Kills Tens of Thousands Each Year. Here's How It Attacks the Body.

"It's a big giant toxic soup of particles and gases," expert says

FDA Greenlights Next-Generation ROS1 Inhibitor for Lung Cancer

Zidesamtinib is indicated for patients who received a prior ROS1 inhibitor

Reproductive Health Should Be Emphasized in Cystic Fibrosis Care, Foundation Says

Clinicians should initiate annual discussions

Novel Antifungal Shows Activity in Valley Fever

Three-quarters of patients had a clinical response in mid-stage study

CDC Suggests Threat of Mold-Associated Illnesses May Be Underappreciated

"It's kind of the first time we've had an estimate like this," the study's senior author says

FDA Approves First mRNA Flu Vaccine

Approval is for people 50 years or older

Dirty Air Worsens Rheumatoid Arthritis Outcomes, Study Shows

Small particulate matter seen as the main culprit

Senators Pan Trump Officials' Demand for Health Data as Condition for Lifesaving Aid

"These new demands set an alarming precedent," Democratic senators noted

Real-World Study Backs Mepolizumab in Rhinosinusitis With Nasal Polyps

— 20% of patients were on their way to remission

Overheard in Medicine: Pandemic Wounds Reopened

Overhead in Medicine is a Medscape digest that surfaces a few of the week’s top posts from major medical subreddits.

Tenax Heart Drug Fails to Improve Walking Results in Study, Shares Plunge

Tenax Therapeutics said on Monday its experimental drug did not significantly improve how far patients could walk compared with ⁠placebo in a late-stage trial for a...

Ivacaftor Boosts Height and Lung Function in Cystic Fibrosis

Children and young adults with cystic fibrosis, especially those with severe CFTR variants, who receive ivacaftor have improved height and lung capacity than peers who do not receive ivacaftor.

Housing Aid Linked to Better NSCLC Survival

Housing assistance was associated with lower mortality among older adults with NSCLC, but the survival advantage was not explained by differences in guideline-concordant treatment.

More Bronchiectasis Patients Benefit From HEMT

Data from the US Bronchiectasis and NTM Research Registry show improvements in cough and exacerbations with highly effective modulator therapy.

Integrating Evolving IO Strategies in Frontline mNSCLC Management

Integrating Evolving IO Strategies in Frontline mNSCLC Management

Case Report: Paradoxical Bronchoconstriction with Short-Acting Beta Agonist

Clinicians perform pulmonary function tests to find the cause

Recommended News For You

Smart exercise planning could boost recovery for people with cancer

According to research, hospitals can save money and help cancer patients by implementing a basic intervention.

Timely ‘Nudges’ Help Spur Talks on Patient Care Goals

High Success Rate With Conversion Therapy for Unresectable Gastroesophageal Cancer

GLP-1 Drugs Linked to Lower Colorectal Cancer Risk for Diabetes Patients.

For relapsed or resistant DLBCL, odronextamab produced positive results.

Decoding calcifications in breast cancer: Towards personalized medicine

Recommended Articles For You

Engineering the Future of Oncology with CAR- Natural Killer Cell Design & Therapeutics 

Targeting BRAF V600E in mCRC: FOLFOX, Cetuximab & Encorafenib Strategies 

Mast Cell-Tumor Cell Interactions in OSCC: Genetic and microRNA Insights 

Unlocking the Mystery of Ovarian Cancer Staging 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Living near St. Louis-area Coldwater Creek during childhood linked with higher risk of cancer from radiation

2.

Cancer during young adulthood carries long-term mental toll, study finds

3.

Glioma Outcomes Shaped by Subtype More Than Tx Sequence

4.

Massachusetts nurses with brain tumors: Department of Public Health 'in communication' with Newton-Wellesley

5.

Whole Foods Recall; RFK Jr.'s Voting Problem; Glass Particles in Biosimilar

1.

Navigating the Stages of Thyroid Cancer: A Guide for Patients

2.

Understanding Hidrocystoma: Symptoms, Causes, and Treatment Options 

3.

The Science Behind Thrombolytic Drugs and Their Benefits 

4.

Clinical Pharmacology of Hypoxia-Activated Anticancer Prodrugs

5.

Does Lactate Signal Anemia? Exploring the Complexities of Hyperlactatemia and Red Blood Cell Health

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VII

2.

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

3.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

4.

Blood Clotting Disorders Explained

5.

Efficient Management of First line ALK-rearranged NSCLC - Part VIII

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot